Slide 1Blood transfusion 1. Bloodtransfusion in the Netherlands and in the LUMC 2. Haemovigilance 3. Quality indicators 4. Blood transfusion research in Leiden Slide 2 Slide…

1.This report contains the collective views of an international group of experts anddoes not necessarily represent the decisions or the stated policy of the World Health…

PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PE 005-3 25 September 2007 PE 005-3 25 September 2007 PIC/S GMP GUIDE FOR BLOOD ESTABLISHMENTS…

Slide 1Maintaining a Safe and Adequate Supply of Donated Blood During a Severe Emergency Alan E. Williams, Ph.D. Associate Director for Regulatory Affairs, OBRR, CBER, FDA…

Slide 1Practical aspects of emergency response in blood establishments BPAC, August 2011, Gaithersburg Louis M. Katz MD Mississippi Valley Regional Blood Center Davenport,…

Slide 1 CBER 510(k) Challenges and Strategies Susan Finneran Director of Clinical and Regulatory Affairs Slide 2 Copyright © 2009 Haemonetics Corp.2 Background on Haemonetics…

Slide 1 Good Manufacturing Practices for Blood Establishments (GMP for plasma donations) Dr A Padilla Blood Products & related Biologicals Quality Assurance and Safety:…

Slide 1 Vesna Libek MD, PhD Blood transfusion specialist Head of Blood Transfusion Service Deputy manager CHC Zemun Belgrade Lecturer in Blood transfusion education department…

Slide 1 Quality System for Blood Establishments Morris R. Dixon MM,MT(ASCP)SSB Director of Operations Blood Systems Laboratories Dallas, Texas, USA Slide 2 Blood Systems…

Current Considerations on Plasma for Further Manufacturing Obtained from Whole Blood Donors Alan E. Williams, Ph.D. Associate Director for Regulatory Affairs, OBRR, CBER,…